BCYC
Price
$4.37
Change
+$0.13 (+3.07%)
Updated
Aug 21 closing price
Capitalization
305.87M
67 days until earnings call
Intraday BUY SELL Signals
TCRX
Price
$0.78
Change
-$0.00 (-0.00%)
Updated
Aug 21 closing price
Capitalization
52.83M
80 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCYC vs TCRX

BCYC vs TCRX Comparison Chart in %
View a ticker or compare two or three
VS
BCYC vs. TCRX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (BCYC: $4.37 vs. TCRX: $0.78)
Brand notoriety: BCYC and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 121% vs. TCRX: 22%
Market capitalization -- BCYC: $305.87M vs. TCRX: $52.83M
BCYC [@Biotechnology] is valued at $305.87M. TCRX’s [@Biotechnology] market capitalization is $52.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, BCYC is a better buy in the long-term than TCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 5 TA indicator(s) are bullish while TCRX’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 5 bullish, 4 bearish.
  • TCRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than TCRX.

Price Growth

BCYC (@Biotechnology) experienced а +12.05% price change this week, while TCRX (@Biotechnology) price change was +0.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

BCYC is expected to report earnings on Oct 29, 2026.

TCRX is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($306M) has a higher market cap than TCRX($52.8M). TCRX YTD gains are higher at: -22.050 vs. BCYC (-38.277). TCRX has higher annual earnings (EBITDA): -118.65M vs. BCYC (-183.2M). BCYC has more cash in the bank: 510M vs. TCRX (128M). BCYC has less debt than TCRX: BCYC (14.7M) vs TCRX (92.5M). BCYC has higher revenues than TCRX: BCYC (61.2M) vs TCRX (9.14M).
BCYCTCRXBCYC / TCRX
Capitalization306M52.8M580%
EBITDA-183.2M-118.65M154%
Gain YTD-38.277-22.050174%
P/E RatioN/AN/A-
Revenue61.2M9.14M670%
Total Cash510M128M398%
Total Debt14.7M92.5M16%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCTCRX
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BCYC
Daily Signal:
Gain/Loss:
TCRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSMOX26.040.32
+1.24%
Victory RS Mid Cap Growth A
NNTWX30.340.25
+0.83%
Nicholas II N
AIVBX22.210.17
+0.77%
American Funds Intl Vntg A
RGOIX24.790.13
+0.53%
RBC Global Opportunities I
POGCX57.300.27
+0.47%
Putnam Large Cap Growth C

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with BCYC. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then BCYC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+0.43%
BCYC - TCRX
41%
Loosely correlated
+3.07%
NKTX - TCRX
39%
Loosely correlated
+7.69%
MGX - TCRX
38%
Loosely correlated
+2.50%
ACET - TCRX
38%
Loosely correlated
-2.03%
PRME - TCRX
36%
Loosely correlated
+4.63%
More